Atlas Trials

A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer

Clinical trial NCT01874938 · COMPLETED

Trial details

NCT number
NCT01874938
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2013-08-01
Primary completion
2014-08-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.